May 2022

Artenie, A., Luhmann, N., Lim, A. G., Fraser, H., Ward, Z., Stone, J., . . . Vickerman, P. (2022). Methods and indicators to validate country reductions in incidence of hepatitis C virus infection to elimination levels set by WHO. The Lancet Gastroenterology and Hepatology, 7(4), 353-366. doi:10.1016/S2468-1253(21)00311-3

Balakrishnan, K., Haregu, T., Hill, A.O., Young, J.T. and Armstrong, G. (2022). Discrimination experienced by sexual minority males in Australia: Associations with suicidal ideation and depressive symptoms. Journal of Affective Disorders, 305, pp. 173-178. DOI:

Bestry, M., Symons, M., Larcombe, A., Muggli, E., Craig, J., Hutchinson, D., Halliday, J. and Martino, D. (2022). Association of prenatal alcohol exposure with offspring DNA methylation in mammals: a systematic review of the evidence. Clinical Epigenetics, 14, (1). DOI:

Brothers, T. D., & Bahji, A. (2022). Patients With Infective Endocarditis Deserve Evidence-based Addiction Treatment. Annals of Thoracic Surgery, 113(3), 1048-1049. doi:10.1016/j.athoracsur.2021.01.085

Butt, J.C. and Stearne, A. (2022). Kava may be coming to a supermarket or cafe near you. But what is it? Is it safe? The Conversation, March 24.

Chambers, M. S. (2022). Effect of vaping on past-year smoking cessation success of Australians in 2019-evidence from a national survey. Addiction. doi:10.1111/add.15897

Champion, K.E., Chapman, C., Gardner, L.A., Sunderland, M., Newton, N.C., Smout, S., Thornton, L., Hides, L., McBride, N., Allsop, S., Mills, K., Kay-Lambkin, F.J., Teesson, M., Slade, T. and Health4Life Team, _. (2022). Lifestyle risks for chronic disease among Australian adolescents: a cross-sectional survey. Medical Journal of Australia, 216, (3), pp. 156-157. DOI:

Chan, G., Sun, T., Lim, C., Yuen, W. S., Stjepanović, D., Rutherford, B., . . . Leung, J. (2022). An age-period-cohort analysis of trends in psychedelic and ecstasy use in the Australian population. Addictive Behaviors, 127. doi:10.1016/j.addbeh.2021.107216

Chiu, V., Hall, W., Chan, G., Hides, L., & Leung, J. (2022). A Systematic Review of Trends in US Attitudes toward Cannabis Legalization. SUBSTANCE USE & MISUSE. doi:10.1080/10826084.2022.2063893

Choi, S. K. Y., Venetis, C., Ledger, W., Havard, A., Harris, K., Norman, R. J., . . . Chambers, G. M. (2022). Population-wide contribution of medically assisted reproductive technologies to overall births in Australia: temporal trends and parental characteristics. HUMAN REPRODUCTION. doi:10.1093/humrep/deac032

Coleshill, M. J., Baldwin, P., Black, M., Newby, J., Shrestha, T., Haffar, S., . . . Christensen, H. (2022). The Essential Network (TEN): Protocol for an Implementation Study of a Digital-First Mental Health Solution for Australian Health Care Workers During COVID-19. JMIR Research Protocols, 11(3). doi:10.2196/34601

Collings, S., Allan, J., & Munro, A. (2022). Improving treatment for people with cognitive impairment and substance misuse issues: Lessons from an inclusive residential treatment program pilot in Australia. Disabil Health J, 101295. doi:10.1016/j.dhjo.2022.101295

Cossar, R., Stewart, A., Wilkinson, A., Dietze, P., Ogloff, J.R., Aitken, C., Butler, T., Kinner, S.A., Curtis, M., Walker, S., Kirwan, A. and Stoove, M.A. (2022). Emergency department presentations in the first weeks following release from prison among men with a history of injecting drug use in Victoria, Australia: A prospective cohort study. International Journal of Drug Policy, 101. DOI:

Cranney, L., McGill, B., Clare, P. J., & Bauman, A. (2022). Trends in risk factors and management strategies used by people with type 2 diabetes in New South Wales, Australia. Preventive Medicine, 157. doi:10.1016/j.ypmed.2022.107004

Daisy, G., Amy, P., Monica, B., Nadine, E., Robert, P., Penelope, H., & Sutherland, R. (2022). Colorimetric reagent test kit use amongst a sample of people who regularly use ecstasy and/or other illegal stimulants in Australia, 2019-2021. Retrieved from Sydney:

Darke, S., Peacock, A., Duflou, J., Farrell, M., & Lappin, J. (2022). Characteristics of fatal ‘novel’ synthetic opioid toxicity in Australia. Drug and Alcohol Dependence, 232. doi:10.1016/j.drugalcdep.2022.109292

Davies, E. L., Puljevic, C., Gilchrist, G., Potts, L., Zhuparris, A., Maier, L. J., . . . Ferris, J. A. (2022). Impacts of changes in alcohol consumption patterns during the first 2020 COVID-19 restrictions for people with and without mental health and neurodevelopmental conditions: A cross sectional study in 13 countries. International Journal of Drug Policy, 101. doi:10.1016/j.drugpo.2021.103563

Dietze, P., Gerra, G., Poznyak, V., Campello, G., Kashino, W., Dzhonbekov, D., . . . Busse, A. (2022). An observational prospective cohort study of naloxone use at witnessed overdoses, Kazakhstan, Kyrgyzstan, Tajikistan, Ukraine. Bulletin of the World Health Organization, 100(3), 187-195. doi:10.2471/BLT.21.286459

Duko, B., Pereira, G., Tait, R.J., Betts, K., Newnham, J. and Alati, R. (2022). Prenatal alcohol and tobacco exposures and the risk of cannabis use in offspring: Findings from a population-based cohort study. Neurotoxicology and Teratology, 90. DOI:

Duko, B., Pereira, G., Tait, R.J., Betts, K., Newnham, J. and Alati, R. (2022). Prenatal tobacco and alcohol exposures and the risk of anxiety symptoms in young adulthood: A population-based cohort study. Psychiatry Research, 310. DOI:

Dzidowska, M., Raubenheimer, J.E., Dobbins, T., Lee, K.S., Hayman, N., Vnuk, J., Haber, P. and Conigrave, K. (2022). Effects of service-wide support on regularity of alcohol screening of clients in Australian Aboriginal and Torres Strait Islander Community Controlled Health Services: a cluster randomised trial. Addiction Science & Clinical Practice, 17, (1). DOI:

Efunnuga, H., Higgs, P., Walker, S. and O'Keefe, D. (2022). Health service utilisation and access for people who inject drugs during COVID-19. Drug and Alcohol Review. DOI:

Fisher, H., Chantler, T., Denford, S., Finn, A., Hickman, M., Mounier-Jack, S., . . . Audrey, S. (2022). Development of a multicomponent intervention to increase parental vaccine confidence and young people's access to the universal HPV vaccination programme in England: Protocol for a co-design study. BMJ Open, 12(4). doi:10.1136/bmjopen-2022-062050

French, C. E., Denford, S., Brooks-Pollock, E., Wehling, H., & Hickman, M. (2022). Low uptake of COVID-19 lateral flow testing among university students: a mixed methods evaluation. Public Health, 204, 54-62. doi:10.1016/j.puhe.2022.01.002

Gilmore, W. and Gilmore, I. (2022). Has the pandemic exacerbated a men’s health issue often forgotten – alcohol? Trends in Urology & Men’s Health. [In Press]

Haines, S., Savic, M., Nielsen, S., & Carter, A. (2022). Key considerations for the implementation of clinically focused Prescription Drug Monitoring Programs to avoid unintended consequences. International Journal of Drug Policy, 101. doi:10.1016/j.drugpo.2021.103549

Holland, A., Harris, M., Hickman, M., Lewer, D., Shorter, G. W., Horsley, J., . . . Rae, M. (2022). Overdose prevention centres in the UK. The Lancet Public Health, 7(3), e196-e197. doi:10.1016/S2468-2667(22)00038-X

Holmes, J., Fairbrother, H., Livingston, M., Meier, P.S., Oldham, M., Pennay, A. and Whitaker, V. (2022). Youth drinking in decline: What are the implications for public health, public policy and public debate? International Journal of Drug Policy, 102. DOI:

Karlsson, A., Peacock, A., McKetin, R., Ezard, N., & Sutherland, R. (2022). Crystal methamphetamine and use of commercial pipes amongst a sentinel sample of people who regularly use ecstasy and other illicit stimulants in Australia, 2021. Retrieved from Sydney:

Lam, T., Biggs, N., Xia, T., Evans, J., Stevens, J., da Gama, M., . . . Nielsen, S. (2022). Comparing opioid types in the persistence of opioid use following surgical admission: a study protocol for a retrospective observational linkage study comparing tapentadol and oxycodone in Australia. BMJ Open, 12(4), e060151. doi:10.1136/bmjopen-2021-060151

Leggat, G., Livingston, M., Kuntsche, S. and Callinan, S. (2022). Alcohol consumption trajectories over the Australian life course. Addiction. DOI:

Leung, J., Chan, G. C. K., Tan, S. X., McClure-Thomas, C., Degenhardt, L., & Hall, W. (2022). State-Level Prevalence and Associates of Opioid Dependence in the USA. INTERNATIONAL JOURNAL OF ENVIRONMENTAL RESEARCH AND PUBLIC HEALTH, 19(7). doi:10.3390/ijerph19073825

Minoyan, N., Hoj, S. B., Zolopa, C., Vlad, D., Bruneau, J., & Larney, S. (2022). Self-reported impacts of the COVID-19 pandemic among people who use drugs: a rapid assessment study in Montreal, Canada. HARM REDUCTION JOURNAL, 19(1). doi:10.1186/s12954-022-00620-w

Monds, L., Lintzeris, N., Bravo, M., Mills, L., Malcolm, A., Gulliver, R., Wood, W., Harrod, M., Read, P., Nielsen, S., Dietze, P., Lenton, S. and Bleeker, A. (2022). The Overdose Response with Take Home Naloxone (ORTHN) Project: Evaluation of Health Worker Training, Attitudes and Perceptions. Drug and Alcohol Review. [In Press]

O'Donnell, C., Popovich, S., Lee, N. and Hides, L. (2022). Barriers and facilitators to accessing effective clinical supervision and the implementation of a clinical supervision exchange model in the Australian alcohol and other drugs sector. Drug and Alcohol Review. DOI:

Pearce, T., Maple, M., Wayland, S., McKay, K., Woodward, A., Brooks, A., & Shakeshaft, A. (2022). A mixed-methods systematic review of suicide prevention interventions involving multisectoral collaborations. Health Res Policy Syst, 20(1), 40. doi:10.1186/s12961-022-00835-0

Price, O., Sutherland, R., Maher, L., Dietze, P., Crawford, S., & Peacock, A. (2022). Factors associated with intention to vaccinate against COVID 19 among a sample of people in Australia who regularly use ecstasy or other illicit stimulants. Retrieved from Sydney:

Reedy, C., Gilmore, W. and Chikritzhs, T.N. (2022). Estimated alcohol-attributable deaths and hospitalisations in Australia, 2010 to 2017. National Alcohol Indicators, Bulletin 17. National Drug Research Institute, Curtin University, Perth.

Schroeder, S., Drysdale, K., Lafferty, L., Baldry, E., Marshall, A., Higgs, P., Dietze, P., Stoove, M.A. and Treloar, C. (2022). "It's a revolving door": Ego-depletion among prisoners with injecting drug use histories as a barrier to post-release success. International Journal of Drug Policy, 101. DOI:

Stevely, A., Vashishtha, R., Fairbrother, H., Fenton, L., Henney, M., Livingston, M. and Holmes, J. (2022). Are changes in attitudes towards school associated with declining youth drinking? A multi-level analysis of 37 countries. European Journal of Public Health. DOI:

Sun, T., Lim, C. C. W., Rutherford, B. N., Johnson, B., Leung, J., Gartner, C., . . . Chan, G. C. K. (2022). Is smoking reduction and cessation associated with increased e-cigarette use? Findings from a nationally representative sample of adult smokers in Australia. Addictive Behaviors, 127. doi:10.1016/j.addbeh.2021.107217

Talbot, B., Farnbach, S., Tong, A., Chadban, S., Sen, S., Garvey, V., . . . Knight, J. (2022). Patient and Clinician Perspectives on the use of Remote Patient Monitoring in Peritoneal Dialysis. Canadian Journal of Kidney Health and Disease, 9. doi:10.1177/20543581221084499

Thornton, L., Osman, B., Champion, K.E., Green, O., Wescott, A.B., Gardner, L.A., Stewart, C., Visontay, R., Whife, J., Parmenter, B.J., Birrell, L., Bryant, Z., Chapman, C., Lubans, D., Slade, T., Torous, J., Teesson, M. and Van de Ven, P. (2022). Measurement Properties of Smartphone Approaches to Assess Diet, Alcohol Use, and Tobacco Use: Systematic Review. JMIR mHealth and u Health, 10, (2). DOI:

Trudgett, S., Griffiths, K., Farnbach, S., & Shakeshaft, A. (2022). A framework for operationalising Aboriginal and Torres Strait Islander data sovereignty in Australia: Results of a systematic literature review of published studies. EClinicalMedicine, 45. doi:10.1016/j.eclinm.2022.101302

Uporova, J., & Sutherland, R. (2022). Benzodiazepine use amongst a sample of people that inject illicit drugs in Canberra, ACT, prior to and during the COVID 19 pandemic. Retrieved from Sydney:

Warfield, S. C., Bharat, C., Bossarte, R. M., DePhilippis, D., Farrell, M., Hoover, M., . . . Degenhardt, L. (2022). Trends in comorbid opioid and stimulant use disorders among Veterans receiving care from the Veterans Health Administration, 2005–2019. Drug and Alcohol Dependence, 232. doi:10.1016/j.drugalcdep.2022.109310

Williams, J., & Weatherburn, D. (2022). CAN ELECTRONIC MONITORING REDUCE REOFFENDING? Review of Economics and Statistics, 104(2), 232-245. doi:10.1162/rest_a_00954

Winifred, A. D., Jane, R. L., Brian, K., Amponsah-Tawiah, K., & Carole, J. (2022). Mental health and workplace factors: comparison of the Ghanaian and Australian mining industry. BMC Health Serv Res, 22(1), 322. doi:10.1186/s12913-022-07712-0

Wong, R. X. Y., Farrell, M., Degenhardt, L., Memedovic, S., Harvey, S. B., & Petrie, K. (2022). Substance use among vocational trainees in Australia: differences between medical specialties. Intern Med J. doi:10.1111/imj.15729

Wright, T. K., McLaughlin, K., Jensen, M. E., Robijn, A. L., Foureur, M., & Murphy, V. E. (2022). A cross-sectional survey of Australian healthcare professionals' confidence, evidence-based knowledge and guideline use for antenatal asthma management. Aust N Z J Obstet Gynaecol. doi:10.1111/ajo.13525

Yeung, A., Palmateer, N. E., Dillon, J. F., McDonald, S. A., Smith, S., Barclay, S., . . . Hutchinson, S. J. (2022). Population-level estimates of hepatitis C reinfection post scale-up of direct-acting antivirals among people who inject drugs. Journal of Hepatology, 76(3), 549-557. doi:10.1016/j.jhep.2021.09.038